Korro Bio, Inc. Common Stock
Compare this stock
KRRO Stock Report Card
$
100%
Performance
Score:
100/100
KRRO returned 192.66% in the last 12 months. Based on SPY's performance of 13.09%, its performance is above average giving it a score of 100 of 100.
Earnings
Score:
100/100
KRRO has missed earnings 0 times in the last 20 quarters.
Volatility
Score:
100/100
KRRO has had a higher than average amount of volatility over the last 12 months giving it a score of 100 of 100.
Korro Bio, Inc. Common Stock Summary
Nasdaq / KRRO
Healthcare
Biotechnology
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
KRRO scored highly on our reportcard. Here are some similar companies and how they performed.
